Atlas Trials

A First in Human Study to Assess the Safety, Tolerability of LB54640 in in Healthy Overweight and Obese Subjects

Clinical trial NCT06040372 · COMPLETED

Trial details

NCT number
NCT06040372
Sponsor
LG Chem
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
ObeseOverweightHealthy
Start date
2020-03-16
Primary completion
2022-03-30
Enrollment
112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.